Skip to main content

Table 3 VWF: Ag and NLR in relation to stroke risk factors among patients

From: New stroke prognostic factors

ItemsVWFAg mean ± SDt testP valueNLR < 2 (n = 25) No (%)NLR ≥ 2 (n = 35) No (%)Test (χ2)P value
Smoking11.01 ± 2.22  11 (44.0)8 (22.9)3.010.083
No10.85 ± 2.560.230.81914 (56.0)17 (77.1)  
Hypertension11.63 ± 2.43  13 (52.0)12 (34.3)  
No10.38 ± 2.332.010.049*12 (48.0)23 (65.71.880.170
DM11.01 ± 2.23  1 (4.0)19 (54.3)  
No DM10.84 ± 2.560.240.81324 (96.0)16 (45.7)16.59< 0.001*
Hyper cholesterolemia12.02 ± 2.40  6 (24.0)20 (57.1)  
No10.04 ± 2.123.370.001*19 (76.0)15 (42.9)6.520.011*
AF8.51 ± 1.75  5 (20.0)3 (8.6)  
No AF11.27 ± 2.333.200.002*20 (80.0)32 (91.4)1.650.199
Carotid stenosis12.05 ± 2.15  3 (12.0)12 (34.3)  
No10.52 ± 2.432.170.034*22 (88.0)23 (65.7)3.860.049*
Combined risk12.88 ± 1.93  1 (4.0)5 (14.3)  
No10.68 ± 2.402.170.034*24 (96.030 (85.7)1.710.190
Blood group O11.45 ± 2.42  12 (48.0)21 (60.0)  
Non-O10.23 ± 2.321.980.052*13 (52.0)14 (40.00.850.357
Hyperurecemia10.63 ± 2.08  3 (12.0)5 (14.0)  
No10.94 ± 2.500.340.73622 (88.0)30 (86.0)0.070.797
VWF:Ag Mean ± SD   10.66 ± 2.4711.07 ± 2.44t = 0.650.250
BMI (≥ 25)12.18 ± 2.1410.26 ± 2.343.080.003*6 (24.0)14 (40.0)1.680.195
Normal   19 (76.0)21 (60.0)  
  1. *Means highly significant